Toth Financial Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History

Toth Financial Advisory’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.53M	Hold	6,600	–	–	0.15%	113
2026 Q2	$1.59M	Hold	6,600	–	–	0.16%	120
2026 Q1	$1.25M	Buy	+6,600	New	+$1.15M	0.14%	121
2021 Q3	–	Sell	-2,800	Closed	-$497K	–	768
2021 Q2	$497K	Buy	+2,800	New	+$485K	0.08%	151

Other funds holding JAZZ

ACM

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BONH

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return

Toth Financial Advisory's JAZZ Position: Q3 2026 in Review

Toth Financial Advisory held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 6,600 shares worth $1.53M. The position accounts for 0.15% of the portfolio, ranked #113.

Toth Financial Advisory first reported a position in JAZZ in Q2 2021 and has held it in 4 quarters since. The position peaked at $1.59M in Q2 2026. 21 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Toth Financial Advisory held 6,600 shares of Jazz Pharmaceuticals worth $1.53M as of Q3 2026.
Toth Financial Advisory left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
Jazz Pharmaceuticals made up 0.15% of Toth Financial Advisory's portfolio in Q3 2026, its #113 holding.
Toth Financial Advisory first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 4 quarters since.
Toth Financial Advisory's Jazz Pharmaceuticals position peaked at $1.59M in Q2 2026.
21 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.